How to Apply Machine Learning Techniques to Real-World Problems

The area of machine learning is expanding quickly and has the potential to transform a wide range of industries. Businesses and organizations are eager to use these potent tools to solve real-world issues, from healthcare to finance. Yet there are a few important factors that must be taken into account when moving from theory to practice, which can be difficult.

A single example runs through every step below: detecting breast cancer from mammography scans. It is a useful example precisely because it punishes the shortcuts that work fine on a tutorial dataset.

Step 1: Define the Problem

Clearly defining the issue you're seeking to solve is the first step in applying machine learning to a real-world issue. A thorough understanding of the domain and the data that will be utilized to train the model is necessary for this. It is crucial to comprehend the problem's goals, conditions, and restrictions as well as the information and materials that are at your disposal. You can utilize this knowledge to choose the right machine learning algorithms and methodologies.

Defining the problem also means defining what success measures. This is where most real-world projects go wrong before a single line of code is written.

In our example, the challenge is determining from mammography scans whether a patient has breast cancer. The data available includes mammography images of patients with and without the disease.

The obvious requirement would be "a model with high accuracy," and it is the wrong one. Breast cancer appears in roughly 5 of every 1000 screening exams. A model that predicts "no cancer" for every single patient is therefore about 99.5% accurate and completely useless. Accuracy on a rare condition tells you almost nothing.

The two kinds of error also do not cost the same. A false positive means a patient is called back for additional imaging: stressful and expensive, but recoverable. A false negative means a cancer goes undetected until it is larger and harder to treat. The second error is far more serious, so the objective must weight sensitivity above specificity rather than treating the two symmetrically.

A defensible requirement looks more like this: achieve a specified sensitivity, for instance 90%, while holding specificity at or above the level radiologists currently achieve on the same population. That is a target you can actually test against, and it names the tradeoff instead of hiding it.

Step 2: Prepare the Data

Once the problem has been defined, the data must be prepared. This includes cleaning, transforming, and pre-processing the data so that it can be used for machine learning. Preparing data is an important step that can consume up to 80% of the time spent on a machine learning project. It is critical to ensure that the data is consistent, accurate, and relevant to the problem at hand.

In our case, the mammography images are preprocessed to remove any artifacts, and the breast region is segmented from the image. The images are then resized to a consistent resolution and their pixel intensities normalized.

Note what is deliberately not happening here. Extracting hand-crafted measurements such as lesion size, shape, texture and density is a different approach, one that pairs with classical algorithms like support vector machines or random forests. A convolutional network learns its own representation directly from pixels, which makes manual feature extraction redundant. These are two alternative pipelines, not two stages of one pipeline. Choose one and follow it through, because mixing them produces work that the model does not use.

Two details in this step decide whether your final numbers mean anything.

Split the data before you scale it. Normalization parameters must be computed on the training set alone and then applied unchanged to the validation and test sets. Scaling everything first and splitting afterwards leaks information about the test data into training, and inflates your results.

Split by patient, not by image. Each patient contributes several images: two views per breast, sometimes prior exams as well. If the split is done at image level, the same patient's scans land in both training and test sets. The model then recognizes the patient rather than the disease, and reported performance collapses the moment it sees someone new. This is one of the most common reasons published medical imaging results fail to reproduce.

Confront the class imbalance now, not later. With positives at well under 1% of exams, imbalance shapes almost every subsequent decision: whether to oversample positives or weight the loss function, where to place the classification threshold, and which metrics are meaningful. A guide that leaves this out is describing a different, easier problem.

Step 3: Choose the Right Algorithm

There are numerous machine learning algorithms to choose from, and determining which one is best for your problem can be difficult. The algorithm chosen will be determined by the nature of the problem, the available data, and the project's resources and constraints. Linear regression, decision trees, random forests, support vector machines, and neural networks are examples of common algorithms.

Before choosing anything sophisticated, establish two reference points. The first is a trivial baseline, such as always predicting the majority class, which tells you the floor. The second is human performance on the same task, since in a clinical setting the model has to be compared against what radiologists already achieve. Without those two numbers you have no way of knowing whether a complex model is earning its complexity.

The chosen algorithm in our illustration is a convolutional neural network, which is suitable for image classification problems. Given how little labeled medical imaging data is typically available, the practical choice is a network pre-trained on a large general image dataset and then fine-tuned on the mammography data, rather than one trained from scratch.

Step 4: Train the Model

After the data has been prepared and the appropriate algorithm has been chosen, the model must be trained. This entails teaching the machine learning algorithm how to make predictions using the data. To ensure that the model generalizes well, it is critical to use a training set that is representative of real-world data.

This requires three sets, not two, and the distinction matters:

• The training set is what the model learns from.

• The validation set is what you use to compare configurations, tune hyperparameters and decide when to stop training.

• The test set is untouched until the very end. It exists to produce one unbiased estimate of performance, and it can only do that if no decision has ever been made using it.

In our breast cancer example, the CNN is trained on the labeled mammography images, with the split grouped by patient and stratified so that the small proportion of positive cases is represented in every set.

Because labeled medical data is scarce, a single split gives a noisy estimate. K-fold cross-validation, stratified by outcome and grouped by patient, gives a far more reliable picture along with a sense of how much the result varies between folds. That variance is itself information: a model whose performance swings widely across folds is not ready regardless of its average score.

Step 5: Evaluate and Refine the Model

After training the model, the next step is to evaluate its performance and make any necessary adjustments. The model can be fine-tuned or even retrained if necessary, using different algorithms or parameters.

All of that refinement happens on the validation set. This is the single most important rule in the article. The moment you evaluate on the test set, see a disappointing number, adjust a parameter and try again, the test set has been used to make a decision. It is no longer an independent estimate, and the number you eventually publish will be optimistic by an amount you cannot measure. Tune on validation. Touch the test set once, at the end, and report what it says.

Choose metrics that survive the class imbalance. Accuracy does not. The ones that do:

• Sensitivity at a fixed specificity, which maps directly onto the requirement set in Step 1.

• AUROC, for overall discrimination across all thresholds.

• AUPRC, which is more informative than AUROC when positives are rare.

• The confusion matrix at your chosen operating threshold, so the actual number of missed cancers is visible rather than buried inside an average.

Threshold selection is a decision in its own right, not a default. The model outputs a probability; where you cut it determines the balance between missed cancers and unnecessary callbacks. Choose that point deliberately, on the validation set, against the cost asymmetry defined in Step 1.

In our example, if validation performance is inadequate, the response might be more aggressive data augmentation, a different network architecture, adjusted class weights, or a different threshold. Each variant is compared on validation. The test set stays sealed.

Step 6: Deploy the Model

The model is ready to be deployed in the real world once it has been refined. This entails incorporating the model into the organization's existing systems and processes, as well as tracking its performance over time.

For a clinical diagnostic model, two things stand between a good test score and real use.

External validation. A model trained on one hospital's scanners, protocols and patient population routinely degrades when it meets another's. Performance must be confirmed on a genuinely independent dataset from a different site before deployment, not after.

Regulatory approval. Software that informs a diagnosis is a regulated medical device. In the United States that means FDA clearance through a 510(k) or De Novo pathway; in the European Union it means CE marking under the Medical Device Regulation. Both require documented evidence, quality management processes, and typically prospective clinical validation showing the model helps in practice rather than merely scoring well retrospectively. This is not a formality appended to the end of the project. It shapes how the earlier steps must be documented, so plan for it from Step 1.

Once cleared, the model is used in hospitals and clinics as an aid to diagnosis. Mammography images are fed into it, it returns a likelihood that the patient has cancer, and a radiologist or oncologist makes and confirms the diagnosis. The model supports the clinician; it does not replace them.

Monitoring after deployment is continuous rather than occasional. Scanners get replaced, imaging protocols change, patient populations shift, and model performance drifts with them. Track the metrics from Step 5 on live data, and define in advance what level of degradation triggers retraining or withdrawal.

Conclusion

When applying machine learning techniques to real-world problems, several factors must be carefully considered, including problem definition, data preparation, algorithm selection, model training, and deployment.

The steps themselves are not the hard part. What separates a working system from a promising notebook is the discipline inside each step: defining success in terms that reflect the real cost of each error, splitting data so results are honest, keeping the test set untouched until the end, and treating validation and regulation as part of the work rather than obstacles at the end of it. Get those right and machine learning becomes a genuine tool for solving complex problems. Skip them and you get a model that performs beautifully on your own data and fails on everyone else's.